You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia,%20Myelogenous,%20Chronic,%20BCR-ABL%20Positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

    Not yet recruiting
    • Chronic Myelogenous Leukemia
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Oct 12, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    Concomitant Medications at CML Diagnosis

    Completed
    • Chronic Myeloid Leukemia
    • the prevalence of comorbid conditions
    • (no location specified)
    Sep 16, 2023

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 24, 2022

    Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023

      According to Molecular Identification at Diagnosis

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Next Generation Sequencing (DNA and RNA)
      • (no location specified)
      Oct 28, 2022

      Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive
        • Taipei, Taiwan
          National Taiwan University Hospital
        Jul 24, 2022

        Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Dasatinib Pill
        • Ketoconazole Pill
        • Monterrey, Nuevo Leon, Mexico
          Hospital Universitario Dr. José Eleuterio González
        Nov 25, 2022

        Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Jena, Germany
          Universitätsklinikum Jena
        Jan 17, 2023

        Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

        Active, not recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
          • Jena, Germany
            University Hospital Jena
          Jan 17, 2023

          Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

          Completed
          • Leukemia
          • No Intervention
          • Cambridge, Massachusetts
            Takeda
          Feb 28, 2023

          Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

          Recruiting
          • Myeloproliferative Neoplasm
          • +2 more
          • Online Mindfulness Meditation
          • Internet-Based Webinars
          • San Francisco, California
            University of California San Francisco
          Aug 9, 2022

          Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

          Not yet recruiting
          • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
          • (no location specified)
          Jun 7, 2022

          3rd Line Therapy or More to Treat Adult CML- CP in Real World

          Not yet recruiting
          • Chronic Myeloid Leukemia
          • Asciminib
          • (no location specified)
          Oct 16, 2023

          Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

          Active, not recruiting
          • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +6 more
          • Houston, Texas
            M D Anderson Cancer Center
          Dec 2, 2022

          "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

          Not yet recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
            • Sohag, Egypt
              Sohag University Hospital
            Sep 14, 2022

            Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

            Recruiting
            • Acute Myeloid Leukemia
            • +4 more
            • Recombinant Interleukin-7
            • Houston, Texas
              M D Anderson Cancer Center
            Jan 26, 2023

            Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

            Active, not recruiting
            • Acute Lymphoblastic Leukemia
            • +11 more
            • Health Promotion and Education
            • +3 more
            • Columbus, Ohio
              Ohio State University Comprehensive Cancer Center
            Jul 24, 2023

            Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)

            Completed
            • Leukemia, Myelogenous, Chronic
            • CTTQ Dasatinib tablet
            • Sprycel Dasatinib tablet
            • Changchun, Jilin, China
              Affiliated Hospital of Changchun University of Traditional Chine
            Dec 7, 2022

            Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

            Not yet recruiting
            • Tyrosine Kinase Inhibitors
            • Chronic Myeloid Leukemia
            • treatment of TKI in CML
            • Poitiers, France
              Chu Poitiers
            Feb 21, 2023

            Ponatinib in CML Patients in Chronic Phase

            Recruiting
            • Chronic Myeloid Leukemia, Chronic Phase
            • Therapeutic drug monitoring
            • Molecular Response
            • Cagliari, Italy
            • +4 more
            Nov 3, 2023